Repository logo
 
Publication

Macular Edema Secondary to Retinal Vein Occlusion in a Real-Life Setting: a Multicenter, Nationwide, 3-Year Follow-Up Study

dc.contributor.authorCosta, JV
dc.contributor.authorMoura-Coelho, N
dc.contributor.authorAbreu, AC
dc.contributor.authorNeves, P
dc.contributor.authorOrnelas, M
dc.contributor.authorFurtado, MJ
dc.date.accessioned2022-12-29T12:36:36Z
dc.date.available2022-12-29T12:36:36Z
dc.date.issued2021
dc.description.abstractPurpose: To evaluate the presence of macular edema secondary to retinal vein occlusion (RVO)-both central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO)-3 years after diagnosis in patients who underwent intravitreal therapy and to identify potential prognostic factors and biomarkers of persistent macular edema. Methods: National multicenter, observational, exploratory, retrospective cohort study of 104 consecutive patients with macular edema secondary to RVO diagnosed from January 2014 to December 2015 with minimum 3-year follow-up time. Data analyzed included best-corrected visual acuity (BCVA), clinical and demographic data, and spectral domain optical coherence tomography parameters. Results: At final observation, median baseline central retinal thickness significantly improved from baseline 538 to 290 μm (p < 0.001) and complete macular edema resolution was achieved in 51.0% of patients (56.3% and 42.5% in BRVO and CRVO patients, respectively). BCVA also improved (p < 0.01). Logistic regression analysis revealed a relationship between recurrence of macular edema and disorganization of retinal inner layers (DRIL) at baseline (odds ratio = 2.88; p = 0.013). Conclusion: Good long-term anatomical and functional outcomes are achieved with intravitreal treatments in RVO patients. Anatomical success and visual gains seen in the first year were maintained throughout the entire follow-up, though DRIL is a major risk factor for recurrence.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationGraefes Arch Clin Exp Ophthalmol . 2021 Feb;259(2):343-350pt_PT
dc.identifier.doi10.1007/s00417-020-04932-0pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4340
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerlinkpt_PT
dc.subjectAnti-VEGFpt_PT
dc.subjectChronic macular edemapt_PT
dc.subjectDisorganization of retinal inner layers;pt_PT
dc.subjectIntravitreal injectionspt_PT
dc.subjectRetinal vein occlusionpt_PT
dc.subjectVision losspt_PT
dc.subjectHSAC OFTpt_PT
dc.titleMacular Edema Secondary to Retinal Vein Occlusion in a Real-Life Setting: a Multicenter, Nationwide, 3-Year Follow-Up Studypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage350pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage343pt_PT
oaire.citation.titleGraefe's Archive for Clinical and Experimental Ophthalmologypt_PT
oaire.citation.volume259pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Graefe Arch Clin Exp Ophthalmol 2021_343.pdf
Size:
2.62 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections